Sulfonation of curcuminoids: Characterization and contribution of individual SULT enzymes

被引:13
作者
Lu, Xiaoyue [1 ]
Jiang, Kunyu [1 ]
Han, Long [1 ]
Zhang, Maofan [1 ]
Zhou, Yu [1 ]
Ma, Yinglin [1 ]
Zhou, Yiping [1 ]
Meng, Shengnan [1 ]
机构
[1] China Med Univ, Sch Pharm, Dept Pharmaceut, Shenyang 110122, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Curcuminoids; Fingerprint; Substrate inhibition; Sulfonation; SULTs; TANDEM MASS-SPECTROMETRY; UDP-GLUCURONOSYLTRANSFERASES; PHENOL SULFOTRANSFERASE; CACO-2; CELLS; METABOLISM; SULFATION; CANCER; REGIOSELECTIVITY; GLUCURONIDATION; QUANTIFICATION;
D O I
10.1002/mnfr.201400493
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Scope: Poor oral bioavailability of curcuminoids limited their various applications, and one of the main reasons is their rapid metabolism in vivo. Sulfonation via sulfotransferases (SULTs) is an important metabolic pathway for such compounds. The objective of this study is to determine the SULT-isoform-specific metabolic fingerprint, tissue-specific rate, and reaction kinetic profiles to describe the characterization and contribution of curcuminoids sulfonation. Methods and results: Sulfonation of curcuminoids was investigated by using nine expressed SULT isoforms and four pooled human tissue S9 fractions. The results showed that human small intestine is the predominant tissue responsible for sulfonation of curcuminoids. SULT1A3 is a major isoform catalyzing sulfonation of curcumin and demethoxycurcumin, but not for bisdemethoxycurcumin. SULT1B1 is only responsible for sulfonation of curcumin. Although SULT1C4 and 1E1 could highly catalyze the sulfate conjugations toward all the three compounds, the correlativities with human small intestine S9 fractions were much weaker (R-2 = 0.100-0.482). Almost all the kinetic profiles of the SULT isoforms for curcuminoids exhibited substrate inhibition kinetics. Conclusion: This investigation contributed to elucidate the SULT-mediated metabolism and detoxication of curcuminoids at molecular levels and in different organs.
引用
收藏
页码:634 / 645
页数:12
相关论文
共 39 条
[1]  
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[2]   Curcumin and Inflammatory Bowel Disease: Biological Mechanisms and Clinical Implication [J].
Ali, Tauseef ;
Shakir, Faiz ;
Morton, Jordan .
DIGESTION, 2012, 85 (04) :249-255
[3]   Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature [J].
Anand, Preetha ;
Thomas, Sherin G. ;
Kunnumakkara, Ajaikumar B. ;
Sundaram, Chitra ;
Harikumar, Kuzhuvelil B. ;
Sung, Bokyung ;
Tharakan, Sheeja T. ;
Misra, Krishna ;
Priyadarsini, Indira K. ;
Rajasekharan, Kallikat N. ;
Aggarwal, Bharat B. .
BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) :1590-1611
[4]   Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease [J].
Baum, Larry ;
Lam, Christopher Wai Kei ;
Cheung, Stanley Kwok-Kuen ;
Kwok, Timothy ;
Lui, Victor ;
Tsoh, Joshua ;
Lam, Linda ;
Leung, Vivian ;
Hui, Elsie ;
Ng, Chelsia ;
Woo, Jean ;
Chiu, Helen Fung Kum ;
Goggins, William B. ;
Zee, Benny Chung-Ying ;
Cheng, King Fai ;
Fong, Carmen Yuet Shim ;
Wong, Adrian ;
Mok, Hazel ;
Chow, Moses Sing Sum ;
Ho, Ping Chuen ;
Ip, Siu Po ;
Ho, Chung Shun ;
Yu, Xiong Wen ;
Lai, Caroline Yau Lin ;
Chan, Ming-Houng ;
Szeto, Samuel ;
Chan, Iris Hiu Shuen ;
Mok, Vincent .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) :110-113
[5]   Regioselectivity of phase 11 metabolism of luteolin and quercetin by UDP-glucuronosyl transferases [J].
Boersma, MG ;
van der Woude, H ;
Bogaards, J ;
Boeren, S ;
Vervoort, J ;
Cnubben, NHP ;
van Iersel, MLPS ;
van Bladeren, PJ ;
Rietjens, IMCM .
CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (05) :662-670
[6]   A high-throughput quantification method of curcuminoids and curcumin metabolites in human plasma via high-performance liquid chromatography/tandem mass spectrometry [J].
Cao, Yu ;
Xu, Ronald X. ;
Liu, Zhongfa .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2014, 949 :70-78
[7]   Safety and anti-inflammatory activity of curcumin:: A component of tumeric (Curcuma longa) [J].
Chainani-Wu, N .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2003, 9 (01) :161-168
[8]   A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis [J].
Chandran, Binu ;
Goel, Ajay .
PHYTOTHERAPY RESEARCH, 2012, 26 (11) :1719-1725
[9]   Beyond eyeballing: Fitting models to experimental data [J].
Christopoulos, A ;
Lew, MJ .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 35 (05) :359-391
[10]   Curcumin Extract for Prevention of Type 2 Diabetes [J].
Chuengsamarn, Somlak ;
Rattanamongkolgul, Suthee ;
Luechapudiporn, Rataya ;
Phisalaphong, Chada ;
Jirawatnotai, Siwanon .
DIABETES CARE, 2012, 35 (11) :2121-2127